MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 160 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $905,000 | -97.1% | 17,236 | -98.1% | 0.00% | -96.3% |
| Q2 2020 | $30,740,000 | +26.8% | 923,968 | +3.7% | 0.03% | 0.0% |
| Q1 2020 | $24,242,000 | +33.0% | 891,244 | -3.5% | 0.03% | +80.0% |
| Q4 2019 | $18,229,000 | +73.9% | 923,917 | +14.2% | 0.02% | +66.7% |
| Q3 2019 | $10,481,000 | +2.9% | 808,712 | -1.2% | 0.01% | 0.0% |
| Q2 2019 | $10,188,000 | -15.6% | 818,340 | -1.5% | 0.01% | -18.2% |
| Q1 2019 | $12,068,000 | +33.8% | 830,583 | +1.7% | 0.01% | +10.0% |
| Q4 2018 | $9,020,000 | -49.5% | 816,992 | +20.3% | 0.01% | -37.5% |
| Q3 2018 | $17,857,000 | +35.0% | 678,958 | +4.9% | 0.02% | +33.3% |
| Q2 2018 | $13,231,000 | +14.1% | 646,994 | +1.3% | 0.01% | +9.1% |
| Q1 2018 | $11,595,000 | +34.6% | 638,832 | +3.4% | 0.01% | +37.5% |
| Q4 2017 | $8,617,000 | -23.2% | 617,690 | +1.8% | 0.01% | -27.3% |
| Q3 2017 | $11,224,000 | +22.6% | 606,700 | +12.0% | 0.01% | +22.2% |
| Q2 2017 | $9,154,000 | +32.7% | 541,686 | +4.9% | 0.01% | +12.5% |
| Q1 2017 | $6,896,000 | -7.4% | 516,542 | +4.4% | 0.01% | -11.1% |
| Q4 2016 | $7,445,000 | +35.5% | 494,670 | +5.3% | 0.01% | +28.6% |
| Q3 2016 | $5,493,000 | +11.5% | 469,866 | +3.0% | 0.01% | 0.0% |
| Q2 2016 | $4,927,000 | +22.3% | 456,225 | +4.7% | 0.01% | +16.7% |
| Q1 2016 | $4,028,000 | -35.8% | 435,947 | +3.0% | 0.01% | -33.3% |
| Q4 2015 | $6,279,000 | -5.5% | 423,158 | +4.6% | 0.01% | -10.0% |
| Q3 2015 | $6,641,000 | -21.9% | 404,654 | +8.6% | 0.01% | -23.1% |
| Q2 2015 | $8,502,000 | +86.6% | 372,751 | +24.4% | 0.01% | +85.7% |
| Q1 2015 | $4,556,000 | +33.8% | 299,750 | +6.0% | 0.01% | +40.0% |
| Q4 2014 | $3,405,000 | +7.4% | 282,786 | +1.1% | 0.01% | 0.0% |
| Q3 2014 | $3,171,000 | -12.0% | 279,628 | -6.3% | 0.01% | -16.7% |
| Q2 2014 | $3,603,000 | +2.0% | 298,308 | -1.6% | 0.01% | 0.0% |
| Q1 2014 | $3,531,000 | -28.6% | 303,127 | +8.4% | 0.01% | -33.3% |
| Q4 2013 | $4,943,000 | +26.8% | 279,574 | +3.3% | 0.01% | +12.5% |
| Q3 2013 | $3,897,000 | +7.3% | 270,762 | +12.2% | 0.01% | 0.0% |
| Q2 2013 | $3,633,000 | – | 241,225 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |